The largest database of trusted experimental protocols

Monoclonal anti dnp ige

Manufactured by Merck Group
Sourced in United States

Monoclonal anti-DNP-IgE is a laboratory reagent used in research. It is a monoclonal antibody that specifically binds to dinitrophenyl (DNP) conjugated immunoglobulin E (IgE). This product can be used in various immunological techniques to detect and quantify IgE levels.

Automatically generated - may contain errors

4 protocols using monoclonal anti dnp ige

1

In Vitro Cell Culture Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco’s modified Eagle’s medium (DMEM), antibiotics (penicillin and streptomycin), and trypsin-ethylenediaminetetraacetic acid (EDTA) were purchased from Gibco BRL (Grand Island, NY, USA). Fetal bovine serum (FBS) was obtained from Biowest (Kansas City, MO, USA), and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), LPS, 4-nitrophenyl n-acetyl-b-d-glucosaminide (p-NAG), and monoclonal anti-DNP-IgE were supplied by Sigma–Aldrich (St. Louis, MO, USA). DNP-BSA was procured from Invitrogen (Gaithersburg, MD, USA). Primary antibodies against p-p38, p38, p-JNK, JNK, p-ERK, ERK, p-Lyn, Lyn, p-Syk, Syk, p-PLCγ, PLCγ, and β-actin were obtained from Cell Signaling Technology (Danvers, MA, USA), and FcεRIγ, from LSBio (Seattle, WA, USA). SensiFAST SYBR No-ROX kit mix was purchased from Biolines (Seoul, Korea), and human filaggrin, AQP3, and HA ELISA kits were obtained from CUSABIO (Seoul, Korea). Rat basophilic leukemia (RBL-2H3, ATCC® CRL-2256) and murine macrophage (RAW264.7, ATCC® TIB-71) cells were procured from the American Type Culture Collection (ATCC), while human immortalized keratinocyte (HaCaT) cells were obtained from Prof. Lee of Chosun University in Korea.
+ Open protocol
+ Expand
2

Macrophage and Basophil Cell Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco’s modified Eagle’s medium (DMEM), antibiotics (penicillin and streptomycin), fetal bovine serum (FBS), and 0.25% trypsin-ethylenediaminetetraacetic acid (EDTA) were purchased from Gibco BRL (Grand Island, NY, USA). Minimum Essential Medium Eagle, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), lipopolysaccharide (LPS), 4-nitrophenyl n-acetyl-b-d-glucosaminide (p-NAG), and monoclonal anti-DNP-IgE were supplied by Sigma–Aldrich (St. Louis, MO, USA). DNP-BSA was procured from Invitrogen (Gaithersburg, MD, USA). Primary and secondary antibodies were obtained from Santa Cruz (Santa Cruz, CA, USA), Cell signaling (Danvers, MA, USA), and Bio-Rad Laboratories, Inc. (Hercules, CA, USA). The murine macrophage RAW 264.7 cell line was obtained from KCLB (Seoul, Republic of Korea). The rat basophilic leukemia RBL-2H3 cell line was obtained from ATCC (Manassas, VA, USA).
+ Open protocol
+ Expand
3

Saponarin Modulates Inflammatory Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Saponarin (purity > 98%) was obtained from Extrasynthese (Genay, France). Dulbecco’s modified Eagle’s medium (DMEM), antibiotics (penicillin and streptomycin), and trypsin-ethylenediaminetetraacetic acid (EDTA) were obtained from Gibco BRL (Grand Island, NY, USA). Fetal bovine serum (FBS) was purchased from Biowest (Kansas City, MO, USA), and lipopolysaccharide (LPS), monoclonal anti-DNP-IgE, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and 4-nitrophenyl n-acetyl-b-d-glucosaminide (p-NAG) were obtained from Sigma-Aldrich (St. Louis, MO, USA). DNP-BSA was procured from Invitrogen (Carlsbad, CA, USA). Recombinant human TNF-α and IFN-γ were purchased from Peprotech (Rocky Hill, NJ, USA). Primary anti-bodies against ERK, JNK, p38, Lyn, Syk, PLCγ, STAT1, p-ERK, p-JNK, p-p38, p-STAT1, p-Lyn, p-Syk, p-PLCγ, and β-actin were purchased from Cell Signaling Technology (Danvers, MA, USA). Primary antibody against TSLP was purchased from ABclonal (Woburn, MA, USA). Primary antibodies against FcεRIγ were purchased from LSBio (Seattle, WA, USA). The SensiFAST SYBR No-ROX kit mix was purchased from Biolines (Seoul, Korea). RAW264.7 (ATCC® TIB-71) and RBL-2H3 (ATCC® CRL-2256) cells were purchased from the American Type Culture Collection (ATCC). HaCaT cells were obtained from Byoung-Woo Lim of Konkuk University, Korea.
+ Open protocol
+ Expand
4

Measurement of β-Hexosaminidase Release in RBL-2H3 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure β-hexosaminidase release, RBL-2H3 cells were trypsinized and centrifuged, before resuspension in DMEM-FCS and stimulated with monoclonal anti-DNP IgE (0.5 μg/ml; Sigma-Aldrich) overnight. The cells were washed with Siraganian buffer (119 mM NaCl, 5 mM KCl, 5.6 mM glucose, 0.4 mM MgCl2, 25 mM PIPES, 40 mM NaOH, 1 mM CaCl2, and 0.1% BSA) and then treated with or without ST at the indicated concentrations. After incubation for 10 min at 37°C, the cells were challenged with DNP-BSA (100 ng/ml; Sigma-Aldrich) for 45 min at 37°C and then put on ice for 10 min. Culture supernatants were incubated with 1 mM p-nitrophenyl-N-acetyl-ß-D-glucosaminide (p-NAG; Sigma-Aldrich) for one hr at 37°C and then 0.1 N Na2CO3/NaHCO3 (pH 10.0) was added to stop the reaction. Optical density at 405 nm was measured. The inhibition of β-hexosaminidase granule release was calculated using the following equations: %  of  inhibition=TreatedBlankSpontaneousControlBlankSpontaneous, where the Control was defined as the normal allergen-IgE response evoked without ST added; Treated was defined as the normal allergen-IgE response evoked with added ST; Blank was only ST and substrate added to the ELISA plate; and Spontaneous meant that the allergen-IgE response was not evoked and ST was not added.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!